Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-139.25%Return on Equity
VS
Market
Sector
Industry
History
$ 1.02Close
$ 0.85 - $ 4.86 52-Week Range
Ticker Information
Ticker
MRKRCompany Name
MARKER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMARKER THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MRKR - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 10.49M | $ -14.61M | -139.25% |
| 3/31/2025 | $ 14.49M | $ -12.78M | -88.22% |
| 12/31/2024 | $ 18.56M | $ -10.73M | -57.82% |
| 9/30/2024 | $ 7.45M | $ -9.7M | -130.17% |
| 6/30/2024 | $ 9.7M | $ -10.37M | -106.88% |
| 3/31/2024 | $ 11.79M | $ -5.66M | -48.03% |
| 12/31/2023 | $ 14.05M | $ -8.24M | -58.61% |
| 9/30/2023 | $ 16.71M | $ -9.29M | -55.61% |
| 6/30/2023 | $ 19.03M | $ -13.23M | -69.49% |
| 3/31/2023 | $ 15.91M | $ -24.99M | -157.02% |
Key Performance Insights, Last 5 Years
- MARKER THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -82.61%.
- Over the past 5 years, MARKER THERAPEUTICS INC's average ROE has been -97.49%.
- The median ROE for MARKER THERAPEUTICS INC during this period was -91.72%
- MARKER THERAPEUTICS INC reached its highest ROE over the past 5 years at -42.76%.
- The lowest ROE recorded by MARKER THERAPEUTICS INC in the same timeframe -158.56%
MARKER THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for MARKER THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -25.28M ] / Equity [ $ 30.6M ]
(=) ROE [ -82.61% ] MRKR - Return on Equity, Last 5 years
-158.56%
Minimum
Sep 30, 2022
-42.76%
Maximum
Mar 31, 2021
-97.49%
Average
-91.72%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |